319 related articles for article (PubMed ID: 18827060)
1. Annexin A2: biology and relevance to the antiphospholipid syndrome.
Cockrell E; Espinola RG; McCrae KR
Lupus; 2008 Oct; 17(10):943-51. PubMed ID: 18827060
[TBL] [Abstract][Full Text] [Related]
2. Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosis.
Chen PP; Yang CD; Ede K; Wu CC; FitzGerald JD; Grossman JM
Lupus; 2008 Oct; 17(10):916-21. PubMed ID: 18827056
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
Yasuda S; Bohgaki M; Atsumi T; Koike T
Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
[TBL] [Abstract][Full Text] [Related]
4. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo.
Romay-Penabad Z; Montiel-Manzano MG; Shilagard T; Papalardo E; Vargas G; Deora AB; Wang M; Jacovina AT; Garcia-Latorre E; Reyes-Maldonado E; Hajjar KA; Pierangeli SS
Blood; 2009 Oct; 114(14):3074-83. PubMed ID: 19628708
[TBL] [Abstract][Full Text] [Related]
5. A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies.
Allen KL; Fonseca FV; Betapudi V; Willard B; Zhang J; McCrae KR
Blood; 2012 Jan; 119(3):884-93. PubMed ID: 22106343
[TBL] [Abstract][Full Text] [Related]
6. Impaired fibrinolysis in the antiphospholipid syndrome.
Krone KA; Allen KL; McCrae KR
Curr Rheumatol Rep; 2010 Feb; 12(1):53-7. PubMed ID: 20425534
[TBL] [Abstract][Full Text] [Related]
7. Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome.
Rand JH; Wu XX; Quinn AS; Taatjes DJ
Lupus; 2008 Oct; 17(10):922-30. PubMed ID: 18827057
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells.
Borghi MO; Raschi E; Grossi C; Chighizola CB; Meroni PL
Lupus; 2014 Oct; 23(12):1302-4. PubMed ID: 25228733
[TBL] [Abstract][Full Text] [Related]
9. Platelets and the antiphospholipid syndrome.
Urbanus RT; Derksen RH; de Groot PG
Lupus; 2008 Oct; 17(10):888-94. PubMed ID: 18827053
[TBL] [Abstract][Full Text] [Related]
10. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies.
Zhang J; McCrae KR
Blood; 2005 Mar; 105(5):1964-9. PubMed ID: 15471954
[TBL] [Abstract][Full Text] [Related]
11. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome.
Forastiero R; Martinuzzo M
Lupus; 2008 Oct; 17(10):872-7. PubMed ID: 18827051
[TBL] [Abstract][Full Text] [Related]
12. Examining the non-linear relationship between monoclonal antiphospholipid antibody sequence, structure and function.
Giles I; Lambrianides A; Rahman A
Lupus; 2008 Oct; 17(10):895-903. PubMed ID: 18827054
[TBL] [Abstract][Full Text] [Related]
13. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts.
Sorice M; Longo A; Capozzi A; Garofalo T; Misasi R; Alessandri C; Conti F; Buttari B; Riganò R; Ortona E; Valesini G
Arthritis Rheum; 2007 Aug; 56(8):2687-97. PubMed ID: 17665396
[TBL] [Abstract][Full Text] [Related]
14. The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity.
Xie H; Sheng L; Zhou H; Yan J
Br J Haematol; 2014 Jan; 164(2):165-76. PubMed ID: 24180619
[TBL] [Abstract][Full Text] [Related]
15. Activation of endothelial cells by antiphospholipid antibodies--a possible mechanism triggering thrombosis in patients with antiphospholipid syndrome.
Chen PP; Lin YC; Wu KC; Yen JH; Ou TT; Wu CC; Liu HW; Tsai WC
Kaohsiung J Med Sci; 2006 Oct; 22(10):484-90. PubMed ID: 17098680
[TBL] [Abstract][Full Text] [Related]
16. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
17. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
[TBL] [Abstract][Full Text] [Related]
18. [New insights into the pathogenicity of antiphospholipid antibodies].
Yasuda S; Koike T
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Oct; 29(5):311-8. PubMed ID: 17075190
[TBL] [Abstract][Full Text] [Related]
19. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II.
Ma K; Simantov R; Zhang JC; Silverstein R; Hajjar KA; McCrae KR
J Biol Chem; 2000 May; 275(20):15541-8. PubMed ID: 10809787
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.
Cesarman-Maus G; Ríos-Luna NP; Deora AB; Huang B; Villa R; Cravioto Mdel C; Alarcón-Segovia D; Sánchez-Guerrero J; Hajjar KA
Blood; 2006 Jun; 107(11):4375-82. PubMed ID: 16493010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
